PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential. [electronic resource]
Producer: 20171113Description: 1300-1311 p. digitalISSN:- 1097-4652
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- pharmacology
- Carcinoma, Squamous Cell -- drug therapy
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Dose-Response Relationship, Drug
- Enzyme Activation
- Enzyme Activators -- pharmacology
- Female
- Fingolimod Hydrochloride -- pharmacology
- Glycogen Synthase Kinase 3 beta -- metabolism
- Head and Neck Neoplasms -- drug therapy
- Humans
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Middle Aged
- Mouth Neoplasms -- drug therapy
- Multivariate Analysis
- Neoplasm Staging
- Odds Ratio
- Phosphorylation
- Proportional Hazards Models
- Protein Phosphatase 2 -- metabolism
- Risk Factors
- Signal Transduction -- drug effects
- Squamous Cell Carcinoma of Head and Neck
- Time Factors
- Tyrosine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.